AVIL gene responsible for glioblastoma also causes rhabdomyosarcoma, UVA researchers find

Phase I study of CAR T-cell therapy shows clinical activity in glioblastoma

A phase I CAR T-cell therapy trial for the treatment of glioblastoma demonstrated promising clinical activity, according to research published in Nature Medicine.

March 15, 2024

Vol.50 No.11

Clinical Roundup

Sylvester study shows glioblastoma can mimic healthy neurons

A study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborating organizations provides insight into glioblastoma neuron mimicry and potential therapies to prevent treatment resistance.

January 19, 2024

Vol.50 No.03

Funding Opportunities

TGen establishes fellowship program in GBM

The Translational Genomics Research Institute, part of City of Hope, established a fellowship in glioblastoma multiforme research. The Lori Lane/Andrew Spyrow Fellowship honors the lives of Lori Lane and Andrew Spyrow who fought GBM bravely, teaching all of us to experience the joy of life and dedicating their journey to the advancement of treatment improving the quality and longevity of life for those facing this devastating cancer.

December 01, 2023

Vol.49 No.44

Letter To The Editor

“Field of Dread” (continued): Do “forever chemicals” in AstroTurf cause GBM?

A letter to the editor by The Philadelphia Inquirer’s James Neff raises concerns about conflicts of interest in a recent Guest Editorial published in The Cancer Letter. The authors and The Cancer Letter editor respond.

October 27, 2023

Vol.49 No.40

Clinical Roundup

mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentially opening the door for wider use of engineered messenger RNA (mRNA) for cancer therapy.

October 27, 2023

Vol.49 No.40

Guest Editorial

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community

Letter to the editor by The Philadelphia Inquirer’s James NeffWe see far too many patients with glioblastoma (GBM), an aggressive and almost always fatal malignant brain tumor.

September 15, 2023

Vol.49 No.34

By Henry S. Friedman and Kyle M. Walsh

AVIL gene responsible for glioblastoma also causes rhabdomyosarcoma, UVA researchers find

YOU MAY BE INTERESTED IN

Phase I study of CAR T-cell therapy shows clinical activity in glioblastoma

Sylvester study shows glioblastoma can mimic healthy neurons

TGen establishes fellowship program in GBM

“Field of Dread” (continued): Do “forever chemicals” in AstroTurf cause GBM?

mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community

Renew today!

Subscriber content

Login

AVIL gene responsible for glioblastoma also causes rhabdomyosarcoma, UVA researchers find

YOU MAY BE INTERESTED IN

Phase I study of CAR T-cell therapy shows clinical activity in glioblastoma

Sylvester study shows glioblastoma can mimic healthy neurons

TGen establishes fellowship program in GBM

“Field of Dread” (continued): Do “forever chemicals” in AstroTurf cause GBM?

mRNA delivered by extracellular vesicles induces immunotherapy response in glioblastoma

The insinuation that AstroTurf causes GBM has no basis in scienceThe Philadelphia Inquirer series does disservice to brain tumor community

Login

The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community